Thoughts on biotech and pharmaceutical stocks from Bio5C founder, JNap.
Head of Research for Remsen Investors LP, a long/short biopharma fund and owner of Bio5C, an independent biopharma research service. Decent at golf.
The number of free subscribers for JNap’s Biotech Thoughts over time since it was added to the directory.
Healthcare lies at the confluence of science, clinical practice, and regulation. I analyze trends, data, and diseases with eye toward biotech and a touch of humor
Weekly posts on small and mid-cap biotech stocks. 100% independent and reader supported with no company sponsored content or hedge fund compensation of any kind. See free performance posts for more information. Not financial advice, for research purposes.
Institutional-grade research on overlooked small caps. Primary data, mosaic theory, and live portfolio tracking.